Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Leclair

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Nature Reviews. Rheumatology|October 6, 2023
Epidemiology of the idiopathic inflammatory myopathiesThomas Khoo, James B Lilleker, Bernard Yu-Hor Thong, et al.
International Journal of Rheumatic Diseases|January 23, 2025
Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 <math> </math> Antibody-Positive DermatomyositisLiang Chen, Sabrina Fallavollita, Lama Sakr, et al.
The Journal of Rheumatology|June 17, 2020
Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in MyositisValérie Leclair, Océane Landon-Cardinal, Rohit Aggarwal, et al.
Frontiers in Immunology|February 13, 2023
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesisMargherita Giannini, Benjamin Ellezam, Valérie Leclair, et al.
Seminars in Arthritis and Rheumatism|February 9, 2024
Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathiesValérie Leclair, Antonella Notarnicola, Olga Kryštůfková, et al.
Rheumatology (Oxford, England)|May 25, 2024
Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies-a potential lifesaving interventionBoyang Zheng, Ellen Eline, Lillian Xu, et al.
Rheumatology (Oxford, England)|June 19, 2021
Autoantibody profiles delineate distinct subsets of scleromyositisValérie Leclair, Julie D'Aoust, Geneviève Gyger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 31, 2025
A window into intracellular events in myositis through subcellular proteomicsJennifer M Peterson, Valérie Leclair, Olumide E Oyebode, et al.
Autoimmunity Reviews|May 10, 2021
Histopathological features of systemic sclerosis-associated myopathy: A scoping reviewFrédéric Lefebvre, Margherita Giannini, Benjamin Ellezam, et al.
Rheumatology (Oxford, England)|March 23, 2026
Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathiesNathan Barreth, Valérie Leclair, Marie Hudson, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Nature Reviews. Rheumatology|October 6, 2023
Epidemiology of the idiopathic inflammatory myopathiesThomas Khoo, James B Lilleker, Bernard Yu-Hor Thong, et al.
International Journal of Rheumatic Diseases|January 23, 2025
Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 <math> </math> Antibody-Positive DermatomyositisLiang Chen, Sabrina Fallavollita, Lama Sakr, et al.
The Journal of Rheumatology|June 17, 2020
Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in MyositisValérie Leclair, Océane Landon-Cardinal, Rohit Aggarwal, et al.
Frontiers in Immunology|February 13, 2023
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesisMargherita Giannini, Benjamin Ellezam, Valérie Leclair, et al.
Seminars in Arthritis and Rheumatism|February 9, 2024
Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathiesValérie Leclair, Antonella Notarnicola, Olga Kryštůfková, et al.
Rheumatology (Oxford, England)|May 25, 2024
Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies-a potential lifesaving interventionBoyang Zheng, Ellen Eline, Lillian Xu, et al.
Rheumatology (Oxford, England)|June 19, 2021
Autoantibody profiles delineate distinct subsets of scleromyositisValérie Leclair, Julie D'Aoust, Geneviève Gyger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 31, 2025
A window into intracellular events in myositis through subcellular proteomicsJennifer M Peterson, Valérie Leclair, Olumide E Oyebode, et al.
Autoimmunity Reviews|May 10, 2021
Histopathological features of systemic sclerosis-associated myopathy: A scoping reviewFrédéric Lefebvre, Margherita Giannini, Benjamin Ellezam, et al.
Rheumatology (Oxford, England)|March 23, 2026
Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathiesNathan Barreth, Valérie Leclair, Marie Hudson, et al.
Pageof 4